货号:A268467 同义名: GSK484 (hydrochloride);GSK484 hydrochloride
GSK484 HCl是一种可逆、选择性的PAD4抑制剂,IC50为50nM。GSK484通过抑制人类中性粒细胞中的PAD4靶蛋白的瓜氨酸化,并抑制小鼠和人类中性粒细胞形成中性粒细胞外陷阱(NETs)。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | GSK484 HCl exhibits strong affinity for PAD4 in its low-calcium state, with IC50s of 50 nM without calcium and 250 nM with 2 mM calcium. It also concentration-dependently inhibits PAD4's citrullination of the BAEE substrate in the presence of 0.2 mM calcium, as shown by an ammonia release assay[1]. |
Animal study | In a study to determine if PAD4 inhibition could mitigate cancer-related kidney damage, MMTV-PyMT mice received daily treatments of GSK484 HCl at 4 mg/kg for a week. This treatment reduced the number of neutrophils undergoing NETosis in the blood of cancerous mice and significantly lowered the total protein in their urine, indicating improved kidney health. The same dosage of GSK484 HCl reversed kidney dysfunction indicators in tumor-bearing mice as effectively as DNase I treatment, with no observed toxicity[2]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.96mL 0.39mL 0.20mL |
9.80mL 1.96mL 0.98mL |
19.61mL 3.92mL 1.96mL |
CAS号 | 1652591-81-5 |
分子式 | C27H32ClN5O3 |
分子量 | 510.028 |
别名 | GSK484 (hydrochloride);GSK484 hydrochloride |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,2-8°C |
溶解方案 |
DMSO: 120 mg/mL(235.28 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(98.03 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |